FDA investigating 'deficiencies' at plant in China
(NEWSER) - Baxter International has expanded its recall of heparin products as the FDA said the number of deaths possibly linked to the blood thinner rose from 4 to 21, the New York Times reports. The agency said it found "deficiencies" at a Chinese plant that supplied the active ingredient. Baxter, which produces about half of the nation's supply, has now recalled virtually all of its heparin products. More»